THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Drug-tracking project may aid FDA efforts

By Diedtra Henderson
Globe Staff / May 4, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

WASHINGTON -- The withdrawal of the popular painkiller Vioxx from the market in September because of safety concerns shows that federal regulators need a better way to pinpoint potentially hazardous drugs, said the lead author of a journal article that describes a complementary private drug-monitoring system . (Full article: 496 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass